FIELD: medicine, hematology, pharmaceutical chemistry.
SUBSTANCE: invention relates to an agent used in correction of homeostasis disorders in carrying out hemodilution using plasma-substituting solutions of the novel composition. Proposed solution contains crystalloid or colloidal plasma-substituting solution and inhibitor antithrombin III as inhibitor of the blood coagulating system. The proposed plasma-substituting composition provides avoiding complications in carrying out transfusion.
EFFECT: improved and valuable properties of solution.
2 cl, 4 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOUNDS POSSESSING ANTICOAGULANT FUNCTION, BASED ON THEM PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF THROMBOTIC CONDITIONS AND PLASMA-SUBSTITUTING SOLUTION FOR CORRECTION OF HYPERCOAGULATION DISORDERS IN HEMODILUTION | 2007 |
|
RU2353619C2 |
| METHOD OF DETERMINING SPACE-TIME DISTRIBUTION OF PROTEOLYTIC ENZYME ACTIVITY IN HETEROGENEOUS SYSTEM, DEVICE FOR REALISING THEREOF AND METHOD OF DIAGNOSING HEMOSTASIS SYSTEM DISORDERS BY CHANGE OF SPACE-TIME DISTRIBUTION OF PROTEOLYTIC ENZYME ACTIVITY IN HETEROGENIC SYSTEM | 2011 |
|
RU2518247C2 |
| HIGHLY-SELECTIVE INFESTIN 4-BASED INHIBITOR OF CONTACT ACTIVATION | 2013 |
|
RU2556116C2 |
| REAGENT KIT FOR DIAGNOSING DEGREE OF NEUROINFLAMMATION | 2018 |
|
RU2698206C1 |
| FACTOR II AND FIBRINOGEN FOR TREATMENT OF HAEMOSTATIC DISORDERS | 2011 |
|
RU2606155C2 |
| METHOD FOR ASSESSING DYNAMICS AND COMPLETE RETRACTION (STABILIZATION) OF BLOOD CLOT | 2014 |
|
RU2596926C2 |
| METHOD FOR INCLUDING BIOLOGICALLY ACTIVE COMPONENTS IN ERYTHROCYTES BY METHOD OF FLOW HYPOOSMOTIC DIALYSIS | 2021 |
|
RU2791817C1 |
| METHOD FOR ASSESSMENT OF DYNAMICS AND COMPLETENESS OF CONTRACTION OF BLOOD CLOTS FOR PREDICTION OF PROBABILITY OF SPONTANEOUS ABORTION | 2020 |
|
RU2735988C1 |
| METHOD FOR ENRICHING DONOR BLOOD PLASMA CRYOPRECIPITATE WITH FACTOR VIII | 2005 |
|
RU2293570C2 |
| WHOLE BLOOD THROMBINE ACTIVITY TEST | 2006 |
|
RU2422835C2 |
